Pure Global

Comparison of Efficacy Between Two Myopia Control Lenses - Trial NCT06148870

Access comprehensive clinical trial information for NCT06148870 through Pure Global AI's free database. This phase not specified trial is sponsored by Essilor International and is currently Not yet recruiting. The study focuses on Myopia. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06148870
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06148870
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Comparison of Efficacy Between Two Myopia Control Lenses

Study Focus

Myopia

Myopia Control Lens-1 (MCL1)

Interventional

device

Sponsor & Location

Essilor International

Singapore, Singapore

Timeline & Enrollment

N/A

Nov 01, 2023

Apr 01, 2025

50 participants

Primary Outcome

Change in Axial Length

Summary

This is a one-year, mono-centre, randomize, double-masked, monocular cross-over clinical
 trial designed to test and compare the efficacy of the new lens design in slowing down the
 increase of axial length and controlling myopia progression.

ICD-10 Classifications

Myopia
Degenerative myopia
Amblyopia ex anopsia
Ocular myiasis
Myiasis

Data Source

ClinicalTrials.gov

NCT06148870

Device Trial